Amsbio's Newborn Human Foreskin Fibroblasts (NuFF-RQ) have been functionally validated to support the generation of induced pluripotent stem cell (iPSC) colonies providing an optimised feeder layer during mRNA reprogramming.
The NuFF-RQ have been added to the company's range of Mouse Embryonic
Fibroblasts (MEFs) and Newborn Human Foreskin Fibroblasts (NuFFs) for stem
cell culture experimentation. The company's feeder cells are meticulously
derived and comprehensively tested on mouse and human ES stem cells to
ensure robust and consistent performance with every lot. Fully qualified,
ready-to-use feeder cells save you the time and trouble of dealing with an
animal facility, dissections, cell expansion and lot-to-lot variation.
Having undergone comprehensive safety tests including human pathogen and
mycoplasma detection, the company’s feeder cells significantly reduce the
threat of contamination in your iPSC reprogramming experiments..
Founded in 1987, AMS Biotechnology (AMSBIO) is recognised as a leading
international provider of unique & innovative products & custom
services for life sciences research. The AMSBIO range includes over 23,000
polyclonal & monoclonal antibodies, peptides, recombinant proteins,
extracellular matrix, molecular detection reagents, & tissue DNA, RNA,
protein & microarray products. Key research areas include: apoptosis,
cell invasion & migration, cell signaling, DNA damage, electrophoresis,
glycobiology, posttranslational modification & stem cell biology.